| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |